Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
908 DevicesMASS +2.25%68 EV-to-FCF is 575.82 as of Aug. 25, 2026. GuruFocus rates MASS with a GF Score™ of 68/100 and a GF Value™ of $7.06 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 404 Medical Devices & Instruments companies, 908 Devices ranks worse than 98.76% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, 908 Devices's Enterprise Value is $354.13 Mil.
908 Devices's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was $0.62 Mil. Therefore, 908 Devices's EV-to-FCF for today is 575.82.
The historical rank and industry rank for 908 Devices's EV-to-FCF or its related term are showing as below:
MASS'
s EV-to-FCF Range Over the Past 10 Years
Min: -583.32 Med: -3.86 Max: 916.84
Current: 575.82
During the past 8 years, the highest EV-to-FCF of 908 Devices was 916.84. The lowest was -583.32. And the median was -3.86.
MASS's EV-to-FCF is ranked worse than 98.76% of 404
companies
in the Medical Devices & Instruments industry
Industry Median: 24.645
vs MASS: 575.82
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
908 Devices's PE Ratio (TTM) for today is calculated as:
908 Devices's share price for today is $10.92.
908 Devices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.950.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
908 Devices EV-to-FCF Related Terms
908 Devices EV-to-FCF Historical Data
* Premium members only.
The historical data trend for 908 Devices's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 908 Devices's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where 908 Devices's EV-to-FCF falls into.
908 Devices's current Enterprise Value is $354.13 Mil.
908 Devices's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
908 Devices (MASS) has a EV-to-FCF of 575.82 as of Aug. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on 908 Devices and its competitors. According to the industry distribution chart, 908 Devices ranks #399 out of 404 companies in the Medical Devices & Instruments industry, placing it in the top 98.8%.
Is 908 Devices' EV-to-FCF too high?
908 Devices' current EV-to-FCF is 575.82. The Medical Devices & Instruments industry median EV-to-FCF is 24.65. 908 Devices' value of 575.82 is 2236.5% above this industry median. Based on the distribution chart, 908 Devices ranks #399 out of 404 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, 908 Devices has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' EV-to-FCF compare to ELMD and SGHT?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #399 out of 404 companies for EV-to-FCF. This places 908 Devices in the lower half of its industry. The industry median EV-to-FCF is 24.65. 908 Devices' value of 575.82 is 2236.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.65, based on 404 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 908 Devices's current EV-to-FCF of 575.82 is 2236.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on 908 Devices and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current EV-to-FCF is 575.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Significantly Overvalued. The stock's GF Value™ is $7.06, compared to a current price of $10.92 — trading 54.7% above its estimated fair value. The current EV-to-FCF is 575.82 and 2236.5% above the Medical Devices & Instruments industry median of 24.65. 908 Devices' overall GF Score™ is 68/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For 908 Devices (MASS), the current EV-to-FCF is 575.82 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $10.92 is trading 54.7% above its estimated GF Value™ of $7.06.
GuruFocus considers 908 Devices to be Significantly Overvalued.
Key valuation signals for MASS:
EV-to-FCF: 575.82
GF Value™: $7.06 vs. price of $10.92 (54.7% above fair value)
Industry Position: 2236.5% above the Medical Devices & Instruments median (#399 of 404)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
68GF Score
Get the complete analysis for MASS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
